2017-03-23,Affimed Announces Fourth Quarter And Year End 2016 Financial Results And Corporate Update Conference Call
2017-03-15,Affimed To Present At The Oppenheimer 27th Annual Healthcare Conference - New York
2017-03-14,Affimed To Present At The Oppenheimer 27th Annual Healthcare Conference - New York
2017-03-01,Affimed To Present Data On Immune Cell Engagers At The AACR Annual Meeting 2017
2017-02-28,Affimed To Present At The Cowen And Company 37th Annual Health Care Conference
2017-02-08,Affimed To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-01-31,First Clinical Milestone Achieved In Collaboration Between AbCheck And Lilly
2017-01-25,Affimed Announces Closing Of Public Offering Of Common Stock
2017-01-20,Affimed Announces Pricing Of Public Offering Of Common Stock
2017-01-19,Affimed Announces Proposed Public Offering Of Common Stock
2017-01-19,Affimed Announces Proposed Public Offering Of Common Stock
2017-01-11,Affimed Provides Update On NK-Cell Immuno-Oncology Platform
2017-01-04,Affimed And MD Anderson Announce Clinical Immuno-Oncology Development Collaboration
2016-12-06,Affimed Presents New Preclinical Data On Bi- And Trispecific Immune Cell Engagers At ASH
2016-11-09,Affimed To Present At The Jefferies 2016 London Healthcare Conference
2016-11-08,Affimed To Present Preclinical Data On Bi- And Trispecific Immune Cell Engagers At ASH
2016-11-02,Affimed Reports Financial Results For Third Quarter 2016
2016-11-02,Affimed Reports Financial Results For Third Quarter 2016
2016-10-31,Affimed To Present At The Credit Suisse 25th Annual Healthcare Conference
2016-10-26,Affimed Announces Third Quarter 2016 Financial Results And Corporate Update Conference Call
2016-10-04,Affimed Presents Preclinical Data On Lead Candidate AFM13 At The Annual Meeting Of The Society For Natural Immunity
2016-09-22,Affimed To Present At The Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
2016-09-01,Affimed To Present At Upcoming Investor Conferences
2016-08-10,Affimed Reports Financial Results For Second Quarter 2016 And Provides Corporate Update
2016-08-03,Affimed Announces Second Quarter 2016 Financial Results And Corporate Update Conference Call
2016-06-03,These 7 Stocks Under $10 Are About to Break Out
2016-05-31,Affimed To Present At The Jefferies 2016 Healthcare Conference
2016-05-23,Affimed Announces Annual General Meeting Of Shareholders
2016-05-18,Affimed Reports Financial Results For First Quarter 2016
2016-05-17,Affimed To Present At The UBS Global Healthcare Conference -- New York
2016-05-11,Affimed Announces First Quarter 2016 Financial Results And Corporate Update Conference Call
2016-04-25,8 Breakout Stocks Under $10 to Trade for Big Profits
2016-04-21,Affimed Presents Data On AFM13-mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016
2016-04-21,Affimed Presents Data On EGFRwt And EGFRvIII-targeting NK- And T-Cell TandAbs At The AACR Annual Meeting 2016
2016-04-20,Ratings Changes Today
2016-04-01,These 5 Biotech Stocks Under $10 Are About to Break Out
2016-03-30,Affimed Reports Financial Results For Fourth Quarter And Year End 2015
2016-03-23,Affimed Announces Fourth Quarter And Year End 2015 Financial Results And Corporate Update Conference Call
2016-03-17,Affimed To Present Data On NK- And T-Cell Engagers At The AACR Annual Meeting 2016
2016-02-29,Affimed To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-29,Affimed To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-25,5 Stocks Under $10 Set to Soar
2016-02-22,Affimed To Speak At Symposium On Emerging Approaches In Cancer Immunotherapy
2016-02-04,Affimed To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-25,Here's Why Affimed (AFMD) Stock is Popping Today
2016-01-25,Affimed Enters Into Collaboration With Merck To Evaluate AFM13 In Combination With KEYTRUDA(R) (pembrolizumab) For Patients With Hodgkin Lymphoma
2016-01-21,Affimed Appoints Dr. Joerg Windisch As Chief Operating Officer And Adds Dr. Bernhard Ehmer To Supervisory Board
2016-01-20,Affimed To Host Hodgkin's Lymphoma Day With Key Opinion Leaders On January 26th In New York City
2016-01-14,Affimed Announces Addition Of Dr. Andrew Evens To Scientific Advisory Board
2016-01-12,Affimed To Present At Noble Financial Capital Markets' 12th Annual Investor Conference
2015-12-17,5 Stocks Under $10 Set to Soar
2015-12-14,Affimed Added To NASDAQ Biotech IndexÂ®
2015-12-06,Affimed Presents Data Comparing T-cell- And NK-cell-engaging TandAbs AFM11 And AFM12 At ASH
2015-12-06,Affimed Presents Additional Data On Combination Of AFM13 With Checkpoint Inhibitors At ASH
2015-12-02,Affimed Announces Appointment Of Andrew Curtis To Lead Corporate Strategy And Business Development, Expansion Of US Presence
2015-12-01,Affimed To Present At The Oppenheimer 26th Annual Healthcare Conference -- New York
2015-11-11,Affimed CEO To Present At The Jefferies 2015 Global Healthcare Conference -- London
2015-11-10,Affimed Reports Financial Results For Third Quarter 2015
2015-11-06,Affimed Presents Data On Potency Of NK- And T-cell EGFRvIII TandAbs At SITC
2015-11-05,Affimed To Present Data On NK- And T-Cell Engagers At ASH
2015-11-05,Affimed To Present Data On NK- And T-Cell Engagers At ASH
2015-11-03,Affimed Announces Third Quarter 2015 Financial Results And Corporate Update Conference Call
2015-10-30,4 Stocks Under $10 to Trade for Breakouts
2015-10-15,3 Biotech Stocks Under $10 to Buy for Breakout Gains
2015-10-14,Affimed Announces Significant Investment By An Existing Shareholder
2015-10-14,Affimed Announces Significant Investment By An Existing Shareholder
2015-10-06,Affimed To Present Data On Potency Of NK- And T-cell EGFRvIII TandAbs At SITC
2015-09-23,Affimed To Present At The Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
2015-08-04,Affimed Reports Financial Results For Second Quarter 2015
2015-07-28,Affimed Announces Second Quarter 2015 Financial Results And Corporate Update Conference Call
2015-06-30,Affimed Added To Russell 2000(R) Index
2015-06-23,Affimed Announces Opening Of US Operations And Key US-based Hires
2015-06-17,AbCheck And Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership
2015-06-17,AbCheck And Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership
2015-06-03,Affimed Announces Newly Formed Scientific Advisory Board
2015-05-29,Affimed ASCO Data For The CD33/CD3-TandAb Program Demonstrate That CD33 And CD3 Binding Affinities Correlate With Potent T-cell Activation And Cytotoxicity
2015-05-29,Affimed ASCO Data Demonstrate Consistent Potency Of NK-Cell-Engaging Combination Therapy With Checkpoint Modulators
2015-05-27,Affimed To Present At The Jefferies 2015 Healthcare Conference -- New York
2015-05-21,Affimed Reports Financial Results For First Quarter 2015
2015-05-13,Affimed To Present Data At ASCO To Highlight Potency Of NK-Cell-Engaging Combination Therapy With Checkpoint Modulators
2015-05-13,Affimed Announces First Quarter 2015 Financial Results Conference Call
2015-05-13,Affimed Announces First Quarter 2015 Financial Results Conference Call
2015-05-12,Affimed N.V. Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares
2015-05-12,Affimed N.V. Announces Shareholder Meeting
2015-05-12,Affimed To Present At The UBS Global Healthcare Conference - New York
2015-05-06,Affimed N.V. Announces Pricing Of Public Offering Of Common Stock
2015-05-04,Affimed N.V. Announces Proposed Public Offering Of Common Stock
2015-05-04,Affimed N.V. Announces Proposed Public Offering Of Common Stock
2015-03-25,Affimed Announces Financial Results For Fourth Quarter And Year End 2014
2015-03-24,Affimed Completes TandAb Development Candidate Activities Meeting Amphivena's And Janssen's Criteria And Achieves Milestone Ahead Of Schedule
2015-03-18,Affimed Announces Fourth Quarter And Year End 2014 Financial Results Conference Call
2015-03-03,Affimed To Present At The 27th Annual ROTH Conference
2015-02-03,Affimed To Present At The BIO CEO & Investor Conference And At The Leerink Partners Global Healthcare Conference
2015-01-20,Affimed Appoints Dr. Martin Treder As Chief Scientific Officer
2015-01-07,Affimed Receives EUR 2.4 Million ($3 Million) Research Grant From German Government To Fund Trispecific Abs
2014-12-08,Affimed Presents Final Data For AFM13 Phase 1 Trial At ASH
2014-11-18,Affimed Reports Financial Results For Third Quarter 2014
2014-11-12,Affimed To Present At The Jefferies Global Healthcare Conference - London
2014-11-11,Affimed Announces Third Quarter 2014 Financial Results Conference Call
2014-09-17,Affimed Announces Closing Of Initial Public Offering
2014-09-12,Affimed Announces Pricing Of Initial Public Offering
,
,
